Ocugen Inc

Затворен

1.55 -6.63

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.51

Максимум

1.67

Ключови измерители

By Trading Economics

Приходи

-1.5M

-19M

Продажби

1.7M

1.5M

EPS

-0.06

Марж на печалбата

-1,250.946

Служители

116

EBITDA

-987K

-17M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+479.04% upside

Дивиденти

By Acuity

Следващи печалби

31.07.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-190M

437M

Предишно отваряне

8.18

Предишно затваряне

1.55

Ocugen Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

29.06.2026 г., 23:56 ч. UTC

Willis Towers Watson PLC shares declined slightly in after-market trading, reflecting routine price fluctuations. The asset remains above its 20-day moving average.

29.06.2026 г., 23:56 ч. UTC

Skyworks Solutions Inc. shares are lower in after-market hours, continuing to trade below their 20-day moving average amid a trend of lower closes.

29.06.2026 г., 23:52 ч. UTC

Japan's Industrial Production Expected to Rise 1.1% in May 2026 Amidst Market Volatility and Uncertainties

29.06.2026 г., 23:52 ч. UTC

Japan's May unemployment rate holds steady at 2.5%, aligning with market expectations and reflecting labor market stability.

29.06.2026 г., 23:52 ч. UTC

Brazil's S&P Global Services PMI release on July 3, 2026, expected to show continued challenges in the services sector amid stagnant demand and rising inflation pressures.

29.06.2026 г., 23:52 ч. UTC

U.S. Initial Jobless Claims Expected at 220,000 Amid Positive Labor Market Sentiment Ahead of July Release

29.06.2026 г., 23:52 ч. UTC

U.S. JOLTs Job Openings Report Set for June 30, Forecasting 7.3 Million Positions Amid Optimistic Employment Growth Sentiment

29.06.2026 г., 23:52 ч. UTC

ECB Forum on Central Banking to Address Interest Rate Policies Amid Cautious Investor Sentiment and Geopolitical Tensions

29.06.2026 г., 23:52 ч. UTC

Social Media

Microsoft shares are higher in after-market trading amid strong interest in cloud and AI infrastructure, despite a legal challenge over copyright infringement.

29.06.2026 г., 23:51 ч. UTC

U.S. equity markets show mixed performance amid cautious optimism from U.S.-Iran talks and anticipation of key economic data, including Non-Farm Payrolls.

29.06.2026 г., 23:51 ч. UTC

Global equity markets show mixed performance as Asian indices rise on easing U.S.-Iran tensions, while European stocks decline ahead of key U.S. economic data releases.

29.06.2026 г., 23:51 ч. UTC

European equity markets show mixed results amid geopolitical tensions and economic uncertainty, with improved Euro Area consumer confidence but declining UK mortgage approvals.

29.06.2026 г., 23:51 ч. UTC

Asia equity markets mixed as U.S.-Iran talks boost sentiment, while European indices decline ahead of central bank discussions.

29.06.2026 г., 23:51 ч. UTC

ETF Constituents

The Consumer Staples Select Sector SPDR Fund is higher in after-market trading, with Costco and Walmart among the top contributors to performance.

29.06.2026 г., 23:51 ч. UTC

Cognizant Technology Solutions shares are higher in after-market trading, reflecting positive sentiment from broader technology gains and recent geopolitical developments.

29.06.2026 г., 23:46 ч. UTC

United States Copper Index Fund shows modest gains in after-market trading. The asset fluctuated between a low of -1.07% and a high of 0.59%.

29.06.2026 г., 23:46 ч. UTC

T-Mobile US Inc. shares traded roughly flat in after-market hours, influenced by broader gains in technology stocks and a recovery in major averages.

29.06.2026 г., 23:41 ч. UTC

Correlated Moves
ETF Constituents

During after-market hours, GDX traded near unchanged, reflecting contributions from Newmont Corporation and Wheaton Precious Metals amid a modest rise in gold prices.

29.06.2026 г., 23:41 ч. UTC

iShares TIPS Bond ETF is lower in after-market hours, continuing a decline since Monday's close amid unusual volatility, without any specific news identified.

29.06.2026 г., 23:41 ч. UTC

Kraft Heinz Co shares are lower in after-market hours. No specific news was identified to explain the decline, despite recent higher closes.

29.06.2026 г., 23:41 ч. UTC

Macro News
Correlated Moves

Bitcoin is trading higher amid eased geopolitical tensions between the U.S. and Iran, reflecting positive sentiment in the cryptocurrency market.

29.06.2026 г., 23:31 ч. UTC

ETF Constituents

iShares MSCI Germany ETF declines after market close, impacted by EUR/USD rates and SAP's performance. The asset remains below its 20-day moving average.

29.06.2026 г., 23:31 ч. UTC

Verisk Analytics Inc shares are higher in after-market hours, reaching near the upper end of their one-month range amid cautious market optimism and geopolitical developments.

29.06.2026 г., 23:31 ч. UTC

Japan's Household Spending Report on July 6, 2026, Anticipated Amid Strong Retail Growth and Currency Concerns.

29.06.2026 г., 23:31 ч. UTC

Japan's Household Spending Report Set for July 6, Amidst Strong Retail Sales and Yen Decline Concerns.

29.06.2026 г., 23:31 ч. UTC

Shares of Fiserv Inc. are higher in after-market trading, despite earlier declines. Investor sentiment is influenced by geopolitical developments and cautious optimism in the market.

29.06.2026 г., 23:31 ч. UTC

Macro News
ETF Constituents

Energy Select Sector SPDR Fund rises after Gulfport Energy's $83 million acquisition and a decline in the U.S. Dollar Index during after-market trading.

29.06.2026 г., 23:31 ч. UTC

News
Social Media

Comcast shares are higher in after-market trading amid reports of a potential expansion into video games and plans for AI-focused data centers.

29.06.2026 г., 23:26 ч. UTC

MercadoLibre Inc. shares are trading higher in after-market hours, influenced by cautious optimism surrounding U.S.-Iran negotiations and broader market sentiment.

29.06.2026 г., 23:26 ч. UTC

Correlated Moves
ETF Constituents

Digital Realty Trust's decline led to little change in VNQ after-hours.

Сравнение с други в отрасъла

Ценова промяна

Ocugen Inc Прогноза

Ценова цел

By TipRanks

479.04% нагоре

12-месечна прогноза

Среден 9.67 USD  479.04%

Висок 12 USD

Нисък 7 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Ocugen Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

6 ratings

6

Купи

0

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.
help-icon Live chat